Belgium· BE-AMP-SAM349307-00
Cayston 75 mg
A aztreonam product containing aztreonam lysine, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Aztreonam is registered in 16 of 19 countries.
Countries holding a registration under ATC J01DF01 (aztreonam), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Aztreonam · ATC J01DF01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of aztreonam costs, country by country.
Normalised to the WHO defined daily dose (0.225 g), the median price runs from $4.80 in Spain to $107.66 in Switzerland — a ×22 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Aztreonam · price per daily dose (0.225 g)
USD · FX 28 Sept 2026
- CH Switzerland$107.66
- ES Spain$4.80
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Aztreonam Lysine
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Belgium (BE)
- ATC code
- J01DF01
- ATC class
- Aztreonam
- Defined daily dose
- 0.225 g, Inhal
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0752436
- be_apb2926939
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for aztreonam.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aztreonam · interactions on record
40 records
- 10 moderate
- 30 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Levonorgestrel and ethinylestradiolG03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aztreonam in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/26107436-5ee3-4a82-934a-37acdcf398b4 GET /v1/drugs/26107436-5ee3-4a82-934a-37acdcf398b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for nebuliser solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Cayston 75 mg",
"name_fr": "Cayston 75 mg",
"name_nl": "Cayston 75 mg",
"amp_code": "SAM349307-00",
"strengths": [
"75.0000",
"75.0000"
],
"pack_count": 2,
"substances": [
"Aztreonam Lysine",
"Aztreonam",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Aztreonam",
"authorisation_numbers": [
"EU/1/09/543/002",
"EU/1/09/543/001"
]
}See everything about aztreonam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.